Core Viewpoint - Tianjin Tasly Pharmaceutical Group Co., Ltd. announced a cash dividend distribution of 0.21 CNY per share for the first half of 2025, approved at the fourth extraordinary general meeting of shareholders on September 2, 2025 [2][4]. Summary by Sections Dividend Distribution - The cash dividend distribution is set at 0.21 CNY per share, amounting to a total cash distribution of approximately 313.73 million CNY based on a total share capital of 1,493,950,005 shares [2][4]. Distribution Objects - The distribution will be made to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the day before the equity registration date [3]. Implementation Method - For shareholders with unrestricted circulating shares, dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation Limited. Shareholders who have completed designated transactions can collect their cash dividends at their designated securities business department on the dividend distribution date [5]. Special Distribution Cases - Certain entities, such as China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Tasly Biopharmaceutical Industry Group Co., Ltd., and Tianjin New Technology Industry Park Yongsheng Construction Co., Ltd., will receive their cash dividends directly from the company [6]. Taxation Details - For individual shareholders holding shares for over one year, the cash dividend of 0.21 CNY per share is exempt from individual income tax. For those holding shares for one year or less, the tax will be calculated upon the transfer of shares [9]. - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied, resulting in a net cash dividend of 0.189 CNY per share [10]. - For Hong Kong investors, a similar 10% withholding tax applies, leading to a net cash dividend of 0.189 CNY per share [10]. - Other corporate shareholders will not have tax withheld by the company and must determine their tax obligations independently, receiving a cash dividend of 0.21 CNY per share [10].
天士力医药集团股份有限公司2025年半年度权益分派实施公告